DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Pfizer (NYSE: PFE)

31.25 -0.58 (-1.82%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $31.25 -1.82%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $31.67
Previous Close $31.83
Daily Range $31.20 - $31.80
52-Week Range $27.51 - $33.50
Market Cap $196.9B
P/E Ratio 19.65
Dividend (Yield) $1.12 (3.5%)
Ex-Dividend Date
Dividend Pay Date
02/04/15
03/03/15
Volume 43,111,816
Average Daily Volume 26,523,430
Current FY EPS $2.07

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Can Biotech Duplicate Its 2014 Performance, or Is It Time to Jump Ship?

Three Motley Fool healthcare contributors share thoughts on whether biotech stocks can go higher this year.

Moving On From Pfizer's 2009 Dividend Cut

Vaccine Controversy Hits Big Pharma: Who Will Pay?

How much should Big Pharma charge for vaccines used in poor countries? The controversy rages on.

3 Small-Cap Biotech Stocks That Could Be Top Stocks in 2015

Portola Pharmaceuticals, Ophthotech, and Achillion Pharmaceuticals have catalysts ahead that could make them top stocks to watch this year.

Did Researchers Just Discover the Cause of Pancreatic Cancer?

Pancreatic cancer is the fourth-leading cause of cancer-related death, but researchers may have moved one step closer to discovering a cure this past week.

In Case You Missed It, Breast Cancer Detection Just Took a Gigantic Leap Forward

When battling breast cancer, time is of the essence. That's why the discovery of this new breast cancer detection technique really is that big of a deal.

After Hours Most Active for Jan 30, 2015 : PBR, AKRX, BAC, QCOM, PFE, GE, T, WFC, AAPL, MSFT, QQQ,

After Hours Most Active for Jan 30, 2015 : PBR, AKRX, BAC, QCOM, PFE, GE, T, WFC, AAPL, MSFT, QQQ, CMCSA

Regeneron Shows Biotech Investors Have Left Their Wildcatting Days

IPO Preview: Spark Therapeutics

Bristol-Myers Squibb Earnings: Currency Headwinds Take The Shine Off Encouraging New Drug Sales

See More PFE News...

PFE's Top Competitors

PFE $31.25 (-1.82%)
Current stock: PFE
JNJ $100.14 (-2.19%)
Current stock: JNJ
MRK $60.28 (-2.92%)
Current stock: MRK
GSK $44.00 (-2.57%)
Current stock: GSK